Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope.

de Souza MS, Ratto-Kim S, Chuenarom W, Schuetz A, Chantakulkij S, Nuntapinit B, Valencia-Micolta A, Thelian D, Nitayaphan S, Pitisuttithum P, Paris RM, Kaewkungwal J, Michael NL, Rerks-Ngarm S, Mathieson B, Marovich M, Currier JR, Kim JH; Ministry of Public Health–Thai AIDS Vaccine Evaluation Group Collaborators..

J Immunol. 2012 May 15;188(10):5166-76. doi: 10.4049/jimmunol.1102756. Epub 2012 Apr 23.

2.

Comparison of costs for disposable and reusable syringes and needles in Siriraj Hospital.

Danchaivijitr S, Chuenarom W, Kachintorn K, Tangtrakul T.

J Med Assoc Thai. 1992 Mar;75 Suppl 2:11-5.

PMID:
1402493
3.

Symposium: problems in the study and control of nosocomial infections.

Chuenarom W, Pichiansathien W, Wanaying B, Wongsatanapong W, Danchaivijitr S.

J Med Assoc Thai. 1988 Jul;71 Suppl 3:48-51. No abstract available.

PMID:
3411271

Supplemental Content

Loading ...
Support Center